EGFR and breast carcinoma: In another breast cancer cell line, MDA-MB-231 (ER−/PR−/HER2−, EGFR+), a model for triple negative breast cancer, administration of 30 μM curcumin for 48 h reduced phosphorylation of ERK [148].